The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease

A. N. Ananthakrishnan, A. Sakuraba, E. L. Barnes, J. Pekow, Laura E. H. Raffals, M. D. Long, R. S. Sandler

Research output: Contribution to journalArticle

8 Scopus citations

Fingerprint Dive into the research topics of 'The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences